High-Risk IV Medications in Special Patient Populations, 9780857296054
Hardcover
Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or cr…

High-Risk IV Medications in Special Patient Populations

$311.43

  • Hardcover

    160 pages

  • Release Date

    29 June 2011

Check Delivery Options

Summary

Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to g…

Book Details

ISBN-13:9780857296054
ISBN-10:0857296051
Author:Sandra Kane-Gill, Joseph Dasta
Publisher:Springer London Ltd
Imprint:Springer London Ltd
Format:Hardcover
Number of Pages:160
Edition:2011th
Release Date:29 June 2011
Weight:582g
Dimensions:235mm x 155mm
What They're Saying

Critics Review

From the reviews: “This book reviews the use of intravenous medications in patient populations with special considerations, discussing the dosing guidelines, safety concerns, and monitoring parameters. … It is intended for clinicians treating critically ill patients with high-risk intravenous medications. This is a good reference for doctors, nurses, pharmacists, and students in these disciplines to use to become well versed in the safe use of dangerous medications. … This is an excellent book that provides clear, concise information in a very usable format.” (Judith Klevan, Doody’s Review Service, November, 2011)

Returns

This item is eligible for free returns within 30 days of delivery. See our returns policy for further details.